Dividend Focus Stock: This Healthcare Business Generates Profits and Dividends

Above-average yield and growth potential help this biotech retain its long-running investor appeal.

Our Dividend Informer analysts like the prospects of this biotechnology company as it digests a recent large acquisition, finding the current valuation a reasonable balance of risk and reward.

In order to read the full analysis on this featured dividend stock, you’ll need to become a paid subscriber by clicking the button below. If you are already a paid subscriber, then we thank you for your support! Paid subscribers to the Dividend Informer receive completed featured stock write-ups each month, updates on covered companies, and market commentary from our award-winning team of analysts.